NASDAQ:DYN
Oppenheimer downgrades Dyne Therapeutics Inc (DYN) stock to a Perform
Dyne Therapeutics Inc’s filing revealed that its CEO & President Cox John unloaded Company’s shares for reported $35402.0 on Sep ...
Recent Insider Activity Suggests Potential Gains for Dyne Therapeutics Inc (DYN)
Dyne Therapeutics Inc’s filing revealed that its CEO & President Cox John unloaded Company’s shares for reported $35402.0 on Sep ...
Insider Sale Alert: Dyne Therapeutics Inc [DYN] – Is it Time to sell?
In a filing, Dyne Therapeutics Inc revealed its CEO & President Cox John unloaded Company’s shares for reported $35402.0 on ...
Dyne Therapeutics Inc [DYN] Investment Appeal on the Rise
In a filing, Dyne Therapeutics Inc revealed its CEO & President Cox John unloaded Company’s shares for reported $35402.0 on ...
Oppenheimer analysts downgrades a Perform rating for Dyne Therapeutics Inc (DYN)
Dyne Therapeutics Inc’s filing revealed that its CEO & President Cox John unloaded Company’s shares for reported $35402.0 on Sep ...
Dyne Therapeutics Inc (DYN) receives a Perform rating from Oppenheimer
Dyne Therapeutics Inc’s recently made public that its CEO & President Cox John unloaded Company’s shares for reported $35402.0 on ...
